CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 25.50
-0.75 (-2.86%)
At close: Mar 3, 2026
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 5.46 billion as of March 3, 2026. Its market cap has decreased by -50.58% in one year.
Market Cap
5.46B
Enterprise Value
3.25B
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.50
Market Cap Chart
Since September 27, 2017, CHO Pharma's market cap has decreased from 15.00B to 5.46B, a decrease of -63.62%. That is a compound annual growth rate of -11.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 5.62B | -6.58% |
| Dec 31, 2025 | 6.01B | -45.44% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savior Lifetec | 5.88B |
| Steminent Biotherapeutics | 5.85B |
| Sinphar Pharmaceutical | 5.85B |
| AnnJi Pharmaceutical | 5.61B |
| OBI Pharma | 5.50B |
| Locus Cell | 5.42B |
| Panion & Bf Biotech | 5.36B |
| UnicoCell Biomed | 5.22B |